Aclacinomycin
Aclacinomycin A is an anthracycline antineoplastic agent that induces erythroid differentiation in K562 chronic myeloid leukemia cells via p38MAPK activation, sensitizing them to imatinib. It is utilized in cancer research, with studies demonstrating its activity in both in vitro cell culture models and in vivo experimental systems.
Product Specifications
CAS Number
66676-88-8
Storage Conditions
-20°C
Notes
For research use only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog